Broadstreet HEOR

Broadstreet HEOR is a private, independent, women-owned health economics and outcomes research consultancy based in Vancouver, Canada. The firm provides evidence-based services across the drug product life cycle, including health economic modeling, evidence synthesis, observational studies, epidemiology, and data visualization to support value, access, and reimbursement decisions. Its clients appear to include pharmaceutical and healthcare stakeholders seeking support for HTA submissions, payer engagement, clinical development strategy, and post-launch evidence generation. Broadstreet HEOR works across multiple therapeutic areas such as rare disease, gene therapy, oncology, cardiovascular, neurology, neuromuscular, dermatology, infectious disease, and respiratory disease. The company is service-based rather than a drug developer, so it does not appear to maintain a proprietary therapeutic pipeline.